Fig. 5
The levels of bacteria and their metabolites were positively correlated with clinical symptoms. A Concentrations of acetic acid, propionic acid, butyric acid, isobutyric acid, isovalerate acid, and valerate acid in the feces of IBS-C patients before and after linaclotide treatment. B Concentrations of acetic acid, propionic acid, butyric acid, isobutyric acid, isovalerate acid, and valerate acid in the feces of relief and no-relief IBS-C patients after treatment. C Correlations among the Blautia abundance, differential short-chain fatty acid (SCFA) content and clinical symptoms